End-to-end clinical trial execution with meticulous GCP compliance, site management, and monitoring across India and globally.
Clinical operations are a critical component of any successful clinical trial. At Genelife Clinical Research, we prioritize the meticulous execution of protocols, SOPs, strategies, GCP compliance, and regulatory requirements to ensure the timely and successful completion of projects as a leading CRO in India.
Our Clinical Operations team specializes in conducting optimized Pilot, Phase I, Phase II, and Phase III pivotal ANDA and 505(b)(2) NDA studies. These studies have resulted in successful filings for ANDAs, 505(b)(2), and 505(b)(1) NDAs for clients across India and globally — supporting our position as a trusted Clinical Research Organization in India.
First-in-human and Phase II study management with specialized early-phase units providing rapid site activation and patient access across India, Singapore, and Germany.
Large-scale multi-centre Phase III and IV study management with robust monitoring, data quality control, and regulatory-ready deliverables for global submissions.
GCP-Compliant Operations: All clinical operations at Genelife are conducted in strict accordance with ICH-GCP guidelines, CDSCO requirements, and sponsor-specific SOPs — ensuring every study meets international quality and regulatory standards.